Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytomegalovirus Viraemia”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Post-approval studies (Phase 4)Study completedNCT00431353
What this trial is testing

VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients

Who this might be right for
Cytomegalovirus Infections
Hoffmann-La Roche 325
Testing effectiveness (Phase 2)UnknownNCT05432778
What this trial is testing

Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Who this might be right for
CMV Viremia
University Medical Centre Ljubljana 90
Not applicableActive Not RecruitingNCT07015801
What this trial is testing

CMV-specific Donor-derived T Lymphocytes for the Treatment of Recalcitrant CMV Infection in a Patient With Primary Immunodeficiency

Who this might be right for
Cytomegalovirus ViremiaCytomegalovirus PneumoniaT-Lymphocyte Immunodeficiency
University of Calgary 1
Not applicableUnknownNCT04298502
What this trial is testing

The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human

Who this might be right for
Acute LeukemiaCMV ViremiaHematopoietic Stem Cell Transplantation
Peking University People's Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00285259
What this trial is testing

Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT)

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaAcute Myelogenous Leukemia+3 more
Astellas Pharma Inc 112
Not applicableStudy completedNCT04412811
What this trial is testing

Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT

Who this might be right for
Hematologic DiseasesStem Cell Transplant ComplicationsCytomegalovirus Viremia+1 more
Gruppo Italiano Trapianto di Midollo Osseo 1,310
Post-approval studies (Phase 4)Study completedNCT00947141
What this trial is testing

Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)

Who this might be right for
Viraemia
University College, London 165
Testing effectiveness (Phase 2)Study completedNCT01911546
What this trial is testing

Role of Everolimus in Highly Sensitized Patients

Who this might be right for
Highly-sensitized Kidney Transplant Recipients
Joseph Kahwaji, MD, MPH 20
Testing effectiveness (Phase 2)Study completedNCT02136797
What this trial is testing

Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
CMV InfectionPersistent CMV Viremia
Memorial Sloan Kettering Cancer Center 77
Not applicableStudy completedNCT01883206
What this trial is testing

CMV Glycoprotein B (gB) Vaccine Long Term Antibody Response

Who this might be right for
Viraemia
University College, London 48
Not applicableUnknownNCT04320303
What this trial is testing

CMV Infection and Immune Intervention After Transplantation

Who this might be right for
CMV ViremiaTransplantation Infection
Peking University People's Hospital 30
Not applicableStudy completedNCT02370758
What this trial is testing

Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients

Who this might be right for
Cytomegalovirus Viraemia
University Health Network, Toronto 32
Not applicableUnknownNCT01397058
What this trial is testing

Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress

Who this might be right for
Cytomegalovirus ViraemiaStress, PhysiologicalReceptor, Hormonal; Disorder+1 more
University of Athens 275
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Testing effectiveness (Phase 2)Study completedNCT01646645
What this trial is testing

Primary Transplant Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cytomegalovirus
Memorial Sloan Kettering Cancer Center 58
Testing effectiveness (Phase 2)Study completedNCT04018261
What this trial is testing

Virus-specific Activated T Lymphocytes From a Donor in Hematopoietic Progenitor Transplanted Patients

Who this might be right for
CMV ViremiaImmunosuppression-related Infectious Disease
Banc de Sang i Teixits 26
Large-scale testing (Phase 3)Looking for participantsNCT07225972
What this trial is testing

Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone

Who this might be right for
CMVAdV InfectionAdV Reactivation+2 more
New York Medical College 138
Testing effectiveness (Phase 2)Looking for participantsNCT06059391
What this trial is testing

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
City of Hope Medical Center 216
Early research (Phase 1)Study completedNCT00002268
What this trial is testing

A Randomized, Phase I/II Trial to Assess the Safety and Antiviral Effects of Escalating Doses of A Human Anti-Cytomegalovirus Monoclonal Antibody (SDZ MSL-109) in Patients With the Acquired Immunodeficiency Syndrome and CMV Viremia and/or Viruria

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
Sandoz
Not applicableUnknownNCT00004573
What this trial is testing

Kinetics of Response of Cytomegalovirus With Ganciclovir Treatment Using Quantitative Real-Time PCR

Who this might be right for
Cytomegalovirus Infections
National Center for Research Resources (NCRR)
Next Page